These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2453008

  • 21. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW, Figlin R, Godwin D, Piantadosi S.
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of malignant pleural effusion.
    Reshad K, Inui K, Takeuchi Y, Takahashi Y, Hitomi S.
    Chest; 1985 Sep; 88(3):393-7. PubMed ID: 2411478
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Iodized talc pleurodesis for the treatment of pleural effusions.
    Webb WR, Ozmen V, Moulder PV, Shabahang B, Breaux J.
    J Thorac Cardiovasc Surg; 1992 May; 103(5):881-5; discussion 885-6. PubMed ID: 1569770
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS, Kim IJ, Kim SJ, Pak K, Kim K.
    Onkologie; 2011 May; 34(6):298-303. PubMed ID: 21625182
    [Abstract] [Full Text] [Related]

  • 28. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Li DJ.
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Intracavitary administration of recombinant interferon in cancer patients with malignant effusions].
    Takashima S, Saeki T, Saeki H, Tanada M, Takiyama W, Kimura T, Moriwaki S.
    Gan No Rinsho; 1986 Sep; 32(11):1451-7. PubMed ID: 3773273
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Malignant pleural effusions and their treatment by intercostal talc pleurodesis.
    Harley HR.
    Br J Dis Chest; 1979 Apr; 73(2):173-7. PubMed ID: 534605
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Human leukocyte interferon alpha (HLI-alpha) for treatment of pleural effusion caused by non small cell lung cancer. A pilot study.
    Tercelj-Zorman M, Mermolja M, Jereb M, Oman M, Soos E, Petric-Grabnar G, Jereb B.
    Acta Oncol; 1991 Apr; 30(8):963-5. PubMed ID: 1663775
    [Abstract] [Full Text] [Related]

  • 37. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
    Leahy BC, Honeybourne D, Brear SG, Carroll KB, Thatcher N, Stretton TB.
    Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
    [Abstract] [Full Text] [Related]

  • 38. [Palliative treatment of malignant pleural effusions with intrapleural injection of colloidal radioactive gold].
    FAUVET J, COURT P, DUTREIX J, PIERQUIN B, TUBIANA M.
    J Fr Med Chir Thorac; 1956 Jan; 10(1):100-12; discussion, 112-3. PubMed ID: 13332209
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Nursing care of patients treated with intrapleural tetracycline for control of malignant pleural effusion.
    Rossetti AC.
    Cancer Nurs; 1985 Apr; 8(2):103-9. PubMed ID: 3846482
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.